![Scientific Newsletter - web box4](https://curehht.org/wp-content/uploads/2022/03/Scientific-Newsletter-web-box4-scaled-wpcf_400x225.jpg)
Scientific Newsletter
Cure HHT’s biannual newsletter that, based on the importance of each study, centralizes and summarizes select publications about HHT for patients, clinicians, and scientists.
Related Resources
Abstracts – 14th HHT International Scientific Conference (2022)
Scientific Literature – 2023Angiogenesis. This article is open access and free for a certain period of time; otherwise, it is available for purchase directly from the publisher. Click to view resource.
MoreExecutive Summary – 14th HHT International Scientific Conference (2022)
Scientific Literature – 2023Angiogenesis. This article is open access and free for a certain period of time; otherwise it is available for purchase directly from the publisher. Click to view resource.
More![](https://curehht.org/wp-content/uploads/2022/03/Frontlines-March-2022_cvr_web-300x249.jpg)
HHT Frontlines – Scientific Newsletter
Newsletter – 2022Spring 2022. Cure HHT’s biannual newsletter that centralizes and summarizes select and important publications about HHT for patients, clinicians, and scientists. Topic areas: Tacrolimus nasal ointment, topical propranolol, pazopanib, itraconazol, scl…
MoreRelated News
![](https://curehht.org/wp-content/uploads/2024/04/Diagonal-Therapeutics_article-wpv_550x300_center_center.jpg)
A Monumental $128 Million Step Forward for HHT Research
Today is a monumental day for HHT. The new biotechnology company, Diagonal Therapeutics, officially launched and we wanted to share more about why this is news you simply can’t miss! In short, Diagona…
![](https://curehht.org/wp-content/uploads/2022/03/HHT-Academy-Web-post-Image-wpv_150x100_center_center.jpg)